GenEdit: GenEdit Raises $26M Series A
Funding will advance development of NanoGalaxy, the company's proprietary platform of polymer nanoparticles optimized for tissue-selective delivery of genetic medicines,... Read MoreThe post GenEdit Raises $26M Series A appeared first on citybiz.
Read full article »
GenEdit is a California-based biotechnology company that develops and commercializes curative therapies for the treatment of genetic diseases.
Read more